The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 01, 2016
Filed:
Nov. 05, 2014
Applicant:
Scf Pharma Inc., Sainte-Luce, CA;
Inventor:
Samuel Fortin, Sainte-Luce, CA;
Assignee:
SCF PHARMA INC., Sainte-Luce, CA;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/20 (2006.01); A61K 31/047 (2006.01); A61K 31/12 (2006.01); A61K 31/122 (2006.01); A61K 36/02 (2006.01); A61K 36/282 (2006.01); A61K 36/30 (2006.01); A61K 36/48 (2006.01); A61K 36/52 (2006.01); A61K 36/55 (2006.01); A61K 36/9066 (2006.01); A61K 47/14 (2006.01); A61K 31/232 (2006.01); A61K 31/23 (2006.01); A61K 31/202 (2006.01); A61K 9/127 (2006.01);
U.S. Cl.
CPC ...
A61K 31/047 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01); A61K 31/232 (2013.01); A61K 36/02 (2013.01); A61K 36/282 (2013.01); A61K 36/30 (2013.01); A61K 36/48 (2013.01); A61K 36/52 (2013.01); A61K 36/55 (2013.01); A61K 36/9066 (2013.01); A61K 47/14 (2013.01); A61K 9/127 (2013.01); A61K 31/20 (2013.01); A61K 31/202 (2013.01); A61K 31/23 (2013.01);
Abstract
There are provided methods for treating an inflammatory diseases chosen from inflammatory bowel diseases, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, acute lung injury, bronchopulmonary dysplasia, cystic fibrosis, bronchitis, bronchiolitis, arthritis, osteoarthritis, ankylosing spondylitis and rheumatism. The method comprise administering to a subject in need thereof an effective amount of at least one lipid and an effective amount of at least one compound chosen from compounds of the present disclosure. Such compounds are polyunsaturated fatty acid monoglycerides or derivatives thereof.